• What are some steps taken by both the FASB and IASB to move to fair value measurement for financial instruments? In what ways have some of the approaches differed?
• IFRS 9-1: What is component depreciation, and when must it be used?
• IFRS 9-2: What is revaluation of plant assets? When should revaluation be applied?
• IFRS 9-3: Some product development expenditures are recorded as development expenses and others as development costs. Explain the difference between these accounts and how a company decides which classification is appropriate.
• IFRS 10-2: Explain how IFRS defines a contingent liability and provide an example.
• IFRS10-3: Briefly describe some similarities and differences between GAAP and IFRS with respect to the accounting for liabilities.